Cargando…
A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel
OBJECTIVE: To understand the benefit-risk profile for historical and current treatments for MLD. METHODS: A systematic review was conducted on the effectiveness, safety, and costs of MLD treatments: allogeneic haematopoietic stem cell transplantation (HSCT) and atidarsagene autotemcel (arsa-cel) acc...
Autores principales: | Armstrong, Nigel, Olaye, Andrew, Noake, Caro, Pang, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466877/ https://www.ncbi.nlm.nih.gov/pubmed/37644601 http://dx.doi.org/10.1186/s13023-023-02814-2 |
Ejemplares similares
-
A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
por: Horgan, Claire, et al.
Publicado: (2023) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018) -
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
por: Beerepoot, Shanice, et al.
Publicado: (2019)